skip to Main Content
[searchandfilter fields="search,category" post_types="post"]

A Multicenter, Randomized, Active-controlled, Double-blind, Double-dummy, Parallel Group Clinical Trial, Investigating the Efficacy, Safety, and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison to Oral IR-LD/CD in Subjects With Parkinson’s Disease Experiencing Motor Fluctuations (BouNDless)

Sponsor:NeuroDerm Ltd.Brief Summary: This is a multi-center, randomized, double blind, active controlled clinical Study. Following a screening period, eligible subjects…

Read More
Back To Top